Clinical Trial Update: Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Donor Hematopoietic Cell Transplant [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating donor lymphocyte infusion for patients with persistent, relapsed, or progressing cancer after donor hematopoietic cell trans…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Blast Phase Chronic Myelogenous Leukemia Bcr-abl1-positive
• Hodgkin Lymphoma
• Non-hodgkin Lymphoma
• Plasma Cell Myeloma

Drugs mentioned

• Donor Lymphocyte Infusion

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Recurrent Adult Acute Lymphoblastic Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-03-10